- 米国企業
- Elevance Health, Inc.
Elevance Health, Inc.ELV
時価総額
$1255.2億
PER
2010年 12月31日 | 2011年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
Premiums | 53,974 | 55,970 | 66,119 | 68,390 | 73,385 | 78,860 | 83,648 | 85,421 | 94,173 | 104,109 | 117,373 | 133,229 | - |
Product revenue | - | - | - | - | - | - | - | - | - | 10,384 | 12,657 | 14,978 | - |
Other Income | 37 | 41 | 40 | 41 | 43 | 35 | 33 | 5,920 | 8,968 | 6,315 | 6,913 | 7,453 | - |
Total operating revenue | - | - | - | - | - | - | - | - | 103,141 | 120,808 | 136,943 | 155,660 | - |
Net investment income | 803 | 704 | 659 | 724 | 678 | 780 | 867 | 970 | 1,005 | 877 | 1,378 | 1,485 | - |
Net (losses) gains on financial instruments | - | - | - | - | - | - | - | - | - | - | 318 | -550 | - |
Total revenues | 58,802 | 60,711 | 71,024 | 73,874 | 79,157 | 84,863 | 90,039 | 92,105 | 104,213 | 121,867 | 138,639 | 156,595 | - |
Benefit expense | 44,927 | 47,648 | 56,237 | 56,855 | 61,117 | 66,834 | 72,236 | 71,895 | 81,786 | 88,045 | 102,645 | 116,487 | - |
Cost of products sold | - | - | - | - | - | - | - | - | 1,992 | 8,953 | 10,895 | 13,035 | - |
Selling, general and administrative expense | 8,839 | 8,436 | 9,953 | 11,748 | 12,535 | 12,558 | 12,650 | 14,020 | 13,364 | 17,450 | 15,914 | 17,686 | - |
Interest expense | 419 | 430 | 603 | 601 | 653 | 723 | 739 | 753 | 746 | 784 | 798 | 851 | - |
Amortization of Intangible Assets | 242 | 239 | 245 | 221 | 230 | 192 | 168 | 358 | 338 | 361 | 441 | 767 | - |
Loss on extinguishment of debt | - | - | -145 | -81 | 9 | - | -282 | -11 | -2 | -36 | -21 | - | - |
Total expenses | 54,448 | 56,753 | 67,183 | 69,506 | 74,526 | 80,308 | 86,076 | 87,037 | 98,228 | 115,629 | 130,714 | 148,826 | - |
Income before income tax expense | 4,354 | 3,958 | 3,840 | 4,368 | 4,631 | 4,555 | 3,964 | 5,068 | 5,985 | 6,238 | 7,925 | 7,769 | - |
Income tax expense | 1,467 | 1,311 | - | 1,808 | 2,071 | 2,086 | 121 | 1,318 | 1,178 | 1,666 | 1,830 | 1,750 | - |
Net income | - | - | - | - | - | - | - | - | - | - | 6,095 | 6,019 | - |
Net loss attributable to noncontrolling interests | - | - | - | - | - | - | - | - | - | - | -9 | -6 | - |
Shareholders’ net income | 2,887 | 2,647 | 2,490 | 2,570 | 2,560 | 2,470 | 3,843 | 3,750 | 4,807 | 4,572 | 6,104 | 6,025 | - |
Earnings Per Share, Basic | 7.03 | 7.35 | 8.34 | 9.31 | 9.73 | 9.39 | 14.7 | 14.53 | 18.81 | 18.23 | 25.04 | 25.1 | - |
Earnings Per Share, Diluted | 6.94 | 7.25 | 8.2 | 8.99 | 9.38 | 9.21 | 14.35 | 14.19 | 18.47 | 17.98 | 24.73 | 24.81 | - |
Dividends per share | - | 1 | 1.5 | 1.75 | 2.5 | 2.6 | 2.7 | 3 | 3.2 | 3.8 | 4.52 | 5.12 | 5.92 |